Identification of Predictive Markers for the Generation of Well-Differentiated Human-Induced Pluripotent Stem Cell-Derived Kidney Organoids

被引:2
|
作者
Du, Zhaoyu [1 ]
Shankar, Anusha S. [1 ]
van den Bosch, Thierry P. P. [2 ]
Korevaar, Sander S. [1 ]
Clahsen-van Groningen, Marian [2 ]
Hoorn, Ewout J. [1 ]
Gribnau, Joost [3 ,4 ]
Reinders, Marlies E. J. [1 ]
Baan, Carla C. [1 ]
Hoogduijn, Martin J. [1 ]
机构
[1] Univ Med Ctr, Erasmus MC Transplant Inst, Dept Internal Med, Div Nephrol & Transplantat,Erasmus MC, POB 2040, NL-3000 CA Rotterdam, Netherlands
[2] Univ Med Ctr, Dept Pathol, Erasmus MC, Rotterdam, Netherlands
[3] Univ Med Ctr, Dept Dev Biol, Erasmus MC, Rotterdam, Netherlands
[4] Univ Med Ctr, iPS Core Facil, Erasmus MC, Rotterdam, Netherlands
关键词
induced pluripotent stem cells; kidney organoid; differentiation; tissue regeneration; E-CADHERIN; TGF-BETA; SPECIFICATION; FIBROBLASTS; DEFINES; GROWTH; SIX2;
D O I
10.1089/scd.2021.0197
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Human-induced pluripotent stem cell (iPSC)-derived kidney organoids have the potential to advance studies to kidney development and disease. However, reproducible generation of kidney organoids is a challenge. A large variability in the percentage of nephron structures and the expression of kidney-specific genes was observed among organoids, showing no association with iPSC lines. To associate the quality of kidney organoid differentiation with predictive markers, a ranking system was developed based on the ratio of nephron structure determined by histological examination. Well-differentiated organoids were defined as organoids with >30% nephron structure and vice versa. Subsequently, correlations were made with expression profiles of iPSC markers, early kidney development markers, and fibrosis markers. Higher expression of sex-determining region Y-box 2 (SOX2) during differentiation was associated with poorly differentiated kidney organoid. Furthermore, early secretion of basic fibroblast growth factor (FGF2) predicted poorly differentiated kidney organoid. Of interest, whereas cadherin-1 (CDH1) expression in kidney organoids indicates distal tubules formation, onefold higher CDH1 expression in iPSC predicted poor differentiation. High expression of the stromal progenitor marker Forkhead Box D1 (FOXD1) and significantly increased TGF beta levels were found in well-differentiated kidney organoids. These early expression profiles could predict the outcome of kidney organoid formation. This study helps to improve the robustness of kidney organoid protocols.</p>
引用
收藏
页码:1103 / 1114
页数:12
相关论文
共 50 条
  • [1] IDENTIFICATION OF PREDICTIVE MARKERS FOR THE GENERATION OF WELL-DIFFERENTIATED IPSC-DERIVED KIDNEY ORGANOIDS
    Du, Zhaoyu
    Shankar, Anusha
    van den Bosch, Thierry
    Korevaar, Sander
    Clahsen-van Groningen, Marian
    Hoorn, Ewout
    Gribnau, Joost
    Reinders, Marlies
    Baan, Carla
    Hoogduijn, Martin
    [J]. TRANSPLANT INTERNATIONAL, 2021, 34 : 68 - 68
  • [2] Advancements in Research on Genetic Kidney Diseases Using Human-Induced Pluripotent Stem Cell-Derived Kidney Organoids
    Na, Do Hyun
    Cui, Sheng
    Fang, Xianying
    Lee, Hanbi
    Eum, Sang Hun
    Shin, Yoo Jin
    Lim, Sun Woo
    Yang, Chul Woo
    Chung, Byung Ha
    [J]. CELLS, 2024, 13 (14)
  • [3] Nephrotoxicity assessment of Esculentoside A using human-induced pluripotent stem cell-derived organoids
    Gu, Shuyi
    Wu, Gaosong
    Lu, Dong
    Meng, Guofeng
    Wang, Yu
    Tang, Liming
    Zhang, Weidong
    [J]. PHYTOTHERAPY RESEARCH, 2023,
  • [4] Generation of Human Induced Pluripotent Stem Cell-Derived Bone Marrow Organoids
    Frenz, Stephanie
    Goek, Isabel
    Buser, Maximilian
    Salewskij, Kirill
    Fairley, Savannah
    Conca, Raffaele
    Drexler, Nicole
    Jonsson, Gustav
    Thomas, Moritz
    Mizoguchi, Yoko
    Rudelius, Martina
    Heuser, Thomas
    Marr, Carsten
    Penninger, Josef M.
    Klein, Christoph
    [J]. BLOOD, 2022, 140 : 1682 - 1683
  • [5] Human induced pluripotent stem cell-derived kidney organoids toward clinical implementations
    Garreta, Elena
    Nauryzgaliyeva, Zarina
    Montserrat, Nuria
    [J]. CURRENT OPINION IN BIOMEDICAL ENGINEERING, 2021, 20
  • [6] A Toolbox to Characterize Human Induced Pluripotent Stem Cell-Derived Kidney Cell Types and Organoids
    Vanslambrouck, Jessica M.
    Wilson, Sean B.
    Tan, Ker Sin
    Soo, Joanne Y-C
    Scurr, Michelle
    Spijker, H. Siebe
    Starks, Lakshi T.
    Neilson, Amber
    Cui, Xiaoxia
    Jain, Sanjay
    Little, Melissa Helen
    Howden, Sara E.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 30 (10): : 1811 - 1823
  • [7] Evaluating the usefulness of human-induced pluripotent stem cell-derived intestinal organoids in drug discovery research
    Nakanishi, A.
    Onozato, D.
    Okumura, H.
    Hashita, T.
    Iwao, T.
    Matsunaga, T.
    [J]. TOXICOLOGY LETTERS, 2018, 295 : S259 - S259
  • [8] Human pluripotent stem cell-derived kidney organoids: Current progress and challenges
    Long, Hong-Yan
    Qian, Zu-Ping
    Lan, Qin
    Xu, Yong-Jie
    Da, Jing-Jing
    Yu, Fu-Xun
    Zha, Yan
    [J]. WORLD JOURNAL OF STEM CELLS, 2024, 16 (02): : 114 - 125
  • [9] Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes
    De Assuncao, Thiago M.
    Sun, Yan
    Jalan-Sakrikar, Nidhi
    Drinane, Mary C.
    Huang, Bing Q.
    Li, Ying
    Davila, Jaime I.
    Wang, Ruisi
    O'Hara, Steven P.
    Lomberk, Gwen A.
    Urrutia, Raul A.
    Ikeda, Yasuhiro
    Huebert, Robert C.
    [J]. LABORATORY INVESTIGATION, 2015, 95 (06) : 684 - 696
  • [10] Generation of human pluripotent stem cell-derived fused organoids with oligodendroglia and myelin
    Kim, Hyosung
    Jiang, Peng
    [J]. STAR PROTOCOLS, 2021, 2 (02):